Published in Am J Gastroenterol on November 01, 1988
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09
Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut (2001) 1.43
Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol (2003) 0.95
IBS and the role of otilonium bromide. Int J Colorectal Dis (2012) 0.89
Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial. Gut (1990) 0.79
Current views on the aetiology and management of the irritable bowel syndrome. Postgrad Med J (1991) 0.75
Complementary feeding patterns in Europe with a special focus on Italy. Nutr Metab Cardiovasc Dis (2012) 2.09
Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36
Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol (1989) 1.27
Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol (1989) 1.23
A new criterion for selection of pharmacokinetic multiexponential equations. J Pharm Sci (1988) 1.19
Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent. J Antimicrob Chemother (1991) 1.16
Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers. Antimicrob Agents Chemother (1992) 1.11
Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03
Suicide in two patients with a diagnosis of probable Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.00
Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers. J Clin Pharmacol (1998) 0.99
Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial. Scand J Gastroenterol Suppl (1982) 0.97
Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci (1993) 0.97
Steady-state pharmacokinetics of rufloxacin in elderly patients with lower respiratory tract infections. Ther Drug Monit (1992) 0.96
Edrophonium chloride for testing colonic contractile activity in man. Acta Physiol Scand (1991) 0.95
Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses. Chemotherapy (1991) 0.94
Distension-stimulated propagated contractions in human colon. Dig Dis Sci (1994) 0.93
Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide. Digestion (1987) 0.92
Impaired colonic motor response to eating in patients with slow-transit constipation. Am J Gastroenterol (1992) 0.92
Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases. Life Sci (1988) 0.90
Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. Ital J Gastroenterol (1997) 0.90
A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B. Hepatology (1996) 0.88
Decreased hepatic glutathione in chronic alcoholic patients. J Hepatol (1986) 0.88
Colonic motor response to eating: a manometric investigation in proximal and distal portions of the viscus in man. Am J Gastroenterol (1989) 0.87
Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res (2011) 0.86
Pharmacokinetics of rufloxacin once daily in patients with lower respiratory tract infections. Infection (1992) 0.85
Increased concentrations of eosinophilic cationic protein in whole-gut lavage fluid from children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (1999) 0.85
A randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients. Gastroenterology (1992) 0.85
Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation. Curr Med Chem (2011) 0.85
Simultaneous occurrence of ipsilateral cluster headache and chronic paroxysmal hemicrania: a case report. Headache (2000) 0.85
Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo. Respiration (1987) 0.84
Pharmacokinetics of rufloxacin in patients with impaired renal function. Antimicrob Agents Chemother (1993) 0.84
Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin. Antimicrob Agents Chemother (1993) 0.84
The penetration of rufloxacin into sites of potential infection in the respiratory tract. J Antimicrob Chemother (1993) 0.84
Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome. Aliment Pharmacol Ther (1989) 0.83
Cardiac autonomic dysfunction in patients with Alzheimer disease: possible pathogenetic mechanisms. Alzheimer Dis Assoc Disord (1998) 0.83
Metabolic syndrome, mild cognitive impairment, and dementia. Curr Alzheimer Res (2011) 0.82
Cytokines and migraine: increase of IL-5 and IL-4 plasma levels. Headache (1998) 0.82
Cytoprotection by PGE2, atropine, pirenzepine and vagotomy in rats. Scand J Gastroenterol Suppl (1982) 0.82
Comparison of the gastric cytoprotective properties of atropine, ranitidine and PGE2 in rats. Eur J Pharmacol (1984) 0.82
Non-familial hemiplegic migraine responsive to naloxone. Cephalalgia (1983) 0.82
The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects. J Clin Endocrinol Metab (1995) 0.82
Gallbladder volume and emptying in diabetics: the role of neuropathy and obesity. J Intern Med (1992) 0.82
Indomethacin-induced intestinal ulcers in rats: effects of salicylazosulfapyridine and dexamethasone. Agents Actions (1985) 0.81
The dyspeptic syndrome in migraine: morphofunctional evaluation on 53 patients. Headache (1996) 0.81
Effect of CCl4 intoxication on the synthesis of beta-lipoprotein fractions in rat liver. Clin Chim Acta (1968) 0.81
Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration. Int J Clin Pharmacol Ther Toxicol (1991) 0.81
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. J Clin Endocrinol Metab (1994) 0.81
Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteers. Br J Clin Pharmacol (1988) 0.80
Portal hemodynamics after meal in normal subjects and in patients with chronic liver disease studied by echo-Doppler flowmeter. Am J Gastroenterol (1987) 0.80
[Congenital dilatation of the segmental intrahepatic bile ducts (J. Caroli's disease). Anatomical study of a further case]. Presse Med (1965) 0.80
Pirenzepine in non-ulcer dyspepsia. A double-blind, placebo controlled trial. Scand J Gastroenterol Suppl (1982) 0.80
Increased plasma levels of glutathione and malondialdehyde after acute ethanol ingestion in humans. J Hepatol (1989) 0.79
Cimetropium bromide as a relaxant for the radiological examination of the stomach and duodenum. Curr Med Res Opin (1986) 0.79
Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans. Gastroenterology (1992) 0.79
Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndrome. Eur J Clin Pharmacol (1988) 0.79
Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial. Gut (1990) 0.79
Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis. Hepatology (1993) 0.79
Urinary excretion of cimetropium bromide after multiple oral doses. Eur J Clin Pharmacol (1987) 0.78
Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group. Clin Pharmacol Ther (1996) 0.78
A double-blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease. Semin Thromb Hemost (1991) 0.78
Use of a new thickened formula for treatment of symptomatic gastrooesophageal reflux in infants. Ital J Gastroenterol Hepatol (1997) 0.78
Discontinuous oral absorption of cimetropium bromide, a new antispasmodic drug. J Pharm Sci (1986) 0.78
Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels. Cephalalgia (1990) 0.78
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty. J Clin Endocrinol Metab (1995) 0.78
Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism (1995) 0.77
Patient education and migraine: a pilot study. Funct Neurol (1998) 0.77
[Glucagon cyclic AMP test. Study in patients with cholestatic hepatitis and with extrahepatic cholestasis]. Med Chir Dig (1976) 0.77
Effect of acute and chronic cimetidine administration on acetaminophen metabolism in humans. Am J Gastroenterol (1987) 0.77
Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: a double-blind randomized echo-Doppler study. Hepatology (1995) 0.77
A multicenter double-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhoea. Arzneimittelforschung (1986) 0.77
[Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results]. Clin Ter (1995) 0.76
Echo-Doppler evaluation of acute flow changes in portal hypertensive patients: flow velocity as a reliable parameter. J Hepatol (1992) 0.76
Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis. Funct Neurol (2001) 0.76
Kinetics of cholinesterase inhibition by eptastigmine in man. Eur J Clin Pharmacol (1991) 0.76
Does acute ethanol really protect against acetaminophen hepatotoxicity? Am J Gastroenterol (1986) 0.75
Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects. Eur J Clin Pharmacol (1993) 0.75
Central acetylcholinesterase inhibition in Alzhemier patients. Ann Neurol (2001) 0.75
Biliary excretion of rufloxacin in humans. Antimicrob Agents Chemother (1993) 0.75
The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure. Br J Clin Pharmacol (1993) 0.75
Response to Mrs. Rapley's comments. Nutr Metab Cardiovasc Dis (2013) 0.75
Comparative studies of the effects of some antimuscarinic agents on gastric damage and pupillary reflex in the rat. Br J Pharmacol (1984) 0.75
Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat. Neuroendocrinology (1995) 0.75
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. J Clin Endocrinol Metab (1994) 0.75
[Evaluation of gallbladder volume and motility with echotomography]. Boll Soc Ital Biol Sper (1982) 0.75
[Plasma malondialdehyde levels: marker for lipid peroxidation in man]. Boll Soc Ital Biol Sper (1988) 0.75
Ranitidine in long-term duodenal ulcer treatment: a multicentre trial. Digestion (1982) 0.75
DHE retard for prophylactic therapy of migraine: efficacy and tolerability. Cephalalgia (1983) 0.75
A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease. Int J Clin Pharmacol Ther Toxicol (1988) 0.75
[Liver damage caused by psychopharmaceuticals]. Clin Ter (1989) 0.75
[Hypersensitivity of a delayed type to the liver antigen in primary biliary cirrhosis]. Arch Ital Mal Appar Dig (1968) 0.75
[Diagnosis and therapy of irritable colon syndrome]. Clin Ter (1988) 0.75
[Efficacy and tolerability of cefoperazone in patients with nosocomial infections]. Clin Ter (1988) 0.75
[Fetal glucose regulation: glycosylated hemoglobin in cord blood]. Boll Soc Ital Biol Sper (1982) 0.75
Erythrocyte membrane ATPase in patients with acute or chronic renal disease. Clin Chim Acta (1972) 0.75